| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.082 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |